← Back
Data updated: Mar 29, 2026
ALMIRALL
DermatologyImmunologyInfectious Disease
Specialty
ALMIRALL is a specialty pharmaceutical company focused on Dermatology, Immunology, Infectious Disease. Key products include SEYSARA.
1969
Since
11
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Competitive Matchups Pro
Loading...
Loading...
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 78%
7 drugs Phase 3: 5 Phase 2: 1 Phase 1: 1
Immunology 20%
2 drugs Phase 1: 5
Infectious Disease 1%
0 drugs Phase 1: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Pfizer big-pharma
Infectious Disease, Dermatology, Immunology
COSETTE other
Dermatology, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Infectious Disease, Dermatology, Immunology
PHARMACIA AND UPJOHN big-pharma
Dermatology, Infectious Disease, Immunology
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Immunology